✦ LIBER ✦

77 The PI3K/AKT pathway: a target for new chemo-radiation approaches?

✍ Scribed by E. Deutsch

Book ID: 118620253
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 333 KB
Volume: 1
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(03)90111-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Drug discovery approaches targeting the

Drug discovery approaches targeting the PI3K/Akt pathway in cancer

✍ Garcia-Echeverria, C; Sellers, W R 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 343 KB

Targeting the PI3K/Akt/mTOR Pathway for

Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy

✍ Justin Cidado, Ben Ho Park 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 322 KB

The PI3K/AKT/mTOR Pathway as a Therapeut

The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer

✍ Slomovitz, B. M.; Coleman, R. L. 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 996 KB

A new player in a deadly game: influenza

A new player in a deadly game: influenza viruses and the PI3K/Akt signalling pathway

✍ Christina Ehrhardt; Stephan Ludwig 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB

Involvement of PI3K/Akt pathway in cell

Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy

✍ Chang, F; Lee, J T; Navolanic, P M; Steelman, L S; Shelton, J G; Blalock, W L; F 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 470 KB

FGFR1/PI3K/AKT signaling pathway is a no

FGFR1/PI3K/AKT signaling pathway is a novel target for antiangiogenic effects of the cancer drug Fumagillin (TNP-470)

✍ Gregory J. Chen; Brian Weylie; Chen Hu; James Zhu; Reza Forough 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 1 views

## Abstract Fibroblast growth factor‐1 (FGF1), a prototypic member of the FGF family, is a potent angiogenic factor. Although FGF‐stimulated angiogenesis has been extensively studied, the molecular mechanisms regulating FGF1‐induced angiogenesis are poorly understood in vivo. Fumagillin, an antiang